How much does Dovato (Lamivudine and Dolutegravir Sodium Tablets) Cost& price without insurance in China?
Dovato® is the commercial brand name of Lamivudine and Dolutegravir Sodium Tablets, an orally active dual-agent fixed-dose anti-HIV combination developed by ViiV Healthcare. Dolutegravir sodium inhibits HIV integrase to prevent viral DNA integration into host genome, while lamivudine blocks HIV reverse transcriptase, synergistically inhibiting HIV-1 proliferation.
Main Indications
First-line treatment for HIV-1 infected treatment-naive adults with no confirmed drug resistance to lamivudine or dolutegravir.
Common Side Effects
Common mild adverse reactions: Headache, fatigue, insomnia, nausea and diarrhea.
Laboratory abnormalities: Occasional transient mild increase of hepatic transaminase.
Severe but manageable risks: Severe allergic reactions, lactic acidosis and immune reconstitution inflammatory syndrome.
Approval Status in China
Dovato® (Lamivudine 300mg/Dolutegravir Sodium 50mg) was approved for sale in China in 2020. It is a prescription medicine covered by China’s Category B medical insurance.
Buy Dovato (Lamivudine and Dolutegravir Sodium Tablets) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
